G, L., J, Y., JS, H., A, I., W, R., A, L., . . . JL, T. (2023). Outcomes of selexipag for treatment of pulmonary arterial hypertension in an Asian population. Annals of the Academy of Medicine, Singapore, 52(4), 219. https://doi.org/10.47102/annals-acadmedsg.2022474
Chicago Style (17th ed.) CitationG, Loo, Yap J, Hon JS, Ismail A, Ruan W, Low A, Lim ST, and Tan JL. "Outcomes of Selexipag for Treatment of Pulmonary Arterial Hypertension in an Asian Population." Annals of the Academy of Medicine, Singapore 52, no. 4 (2023): 219. https://doi.org/10.47102/annals-acadmedsg.2022474.
MLA (9th ed.) CitationG, Loo, et al. "Outcomes of Selexipag for Treatment of Pulmonary Arterial Hypertension in an Asian Population." Annals of the Academy of Medicine, Singapore, vol. 52, no. 4, 2023, p. 219, https://doi.org/10.47102/annals-acadmedsg.2022474.